HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-05-28Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Anti-Retroviral Activity of MK-8558 Monotherapy in Anti-Retroviral-Naïve HIV-1 Infected Participants (MK-8558-002) [Phase 1]
Phase 1 trial evaluating safety, tolerability, PK, and anti-retroviral activity of MK-8558 monotherapy in ART-naïve HIV-1-infected participa…
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: Changes in Weight, Body Composition and Metabolic Parameters After Discontinuing Dolutegravir or Tenofovir Disproxil [Phase 4]
A Phase 4 clinical trial update examining changes in weight, body composition, and metabolic parameters after discontinuation of dolutegravi…
-
CLINICAL_TRIALS trial_result · 2021-05-24Clinical Trial Update: Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children [Phase 2, Phase 3]
Clinical trial update reporting pharmacokinetics, safety, and antiviral activity of the elvitegravir/cobicistat/emtricitabine/tenofovir alaf…
-
CLINICAL_TRIALS trial_result · 2021-05-24Clinical Trial Update: Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women [NA]
A completed clinical trial investigation of combination partner HIV testing strategies for HIV-positive and HIV-negative pregnant women; res…
-
CLINICAL_TRIALS trial_result · 2021-05-19Clinical Trial Update: Daily Trimethoprim-sulfamethoxazole or Weekly Chloroquine Among Adults on ART in Malawi [NA]
Clinical trial update on ART patients in Malawi comparing daily trimethoprim-sulfamethoxazole vs weekly chloroquine; study completed with re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-05-18FDA Approved: ISENTRESS — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for Isentress (raltegravir) from Merck, indicating an approval under NDA205786.
-
CLINICAL_TRIALS trial_result · 2021-05-13Clinical Trial Update: A Safety, Tolerability, Acceptability, and Pharmacokinetic (PK) Study of Cabotegravir (CAB) in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Chinese Men [Phase 1]
Phase 1 safety and PK study of cabotegravir in HIV-uninfected Chinese men completed.
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy [Phase 4]
Phase 4 trial evaluating potential interactions between Truvada and hormone therapy in HIV pre-exposure prophylaxis; completed with results …
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Strength Training and Endurance Exercise for LIFE [NA]
This clinical trial update reports a completed study evaluating strength training and endurance exercise for people living with HIV; results…
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: LYNX: A Novel Mobile App to Support Linkage to HIV/STI Testing PrEP for Young Men Who Have Sex With Men [NA]
Clinical trial update for LYNX, a mobile app designed to support linkage to HIV/STI testing and PrEP for young men who have sex with men; st…
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Assessment of a New "Boosting" Strategy for HIV Pre-exposure Prophylaxis in Healthy Volunteers [EARLY_Phase 1]
Early-phase 1 trial assessing a boosting strategy for HIV pre-exposure prophylaxis in healthy volunteers has completed with results posted.
-
FDA approval · 2021-04-30FDA Approved: ATAZANAVIR — Original Application (Laurus Labs Limited)
The FDA approved Laurus Labs Limited's generic atazanavir through an original ANDA (ANDA 212579).
-
CLINICAL_TRIALS trial_result · 2021-04-29Clinical Trial Update: LRAs United as a Novel Anti-HIV Strategy. [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating LRAs as a novel anti-HIV strategy; completed study.
-
CLINICAL_TRIALS trial_result · 2021-04-27Clinical Trial Update: Post-release Retention in HIV Care for Ex-inmates in South Africa [NA]
This ClinicalTrials.gov update reports the completion of a study evaluating post-release retention in HIV care among ex-inmates in South Afr…
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in PLWH. [Phase 3]
Phase 3 clinical trial evaluating berberine in combination with antiretroviral therapy for metabolic syndrome in people living with HIV; cur…
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: Prospective Cohort Study of Adolescents Living With HIV and Their Caregivers Attending a Psychosocial Programme in Botswana
Prospective cohort study completed; evaluates adolescents living with HIV and their caregivers participating in a psychosocial program in Bo…
-
FDA label_change · 2021-04-22FDA Approved: TROGARZO — Supplemental Application (Theratechnologies Inc.)
The FDA approved a supplemental application for TROGARZO (ibalizumab) from Theratechnologies Inc., resulting in a revised product label.
-
CLINICAL_TRIALS research · 2021-04-22Clinical Trial Update: Innovative Approaches for Minor Consent: Consent 2.0 [NA]
Clinical trial update on Innovative Approaches for Minor Consent: Consent 2.0, investigating consent approaches with HIV-related conditions;…
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community [Phase 4]
Phase 4 demonstration project evaluating PrEP delivery in the transgender community in the San Francisco Bay Area has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T [Phase 1, Phase 2]
Phase 1/2 dose-escalation study assessing cyclophosphamide in HIV-infected individuals on HAART prior to SB-728-T therapy; completed with po…
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Vesatolimod in Antiretroviral Treated Human Immunodeficiency Virus (HIV-1) Infected Controllers [Phase 1]
Phase 1 trial evaluating vesatolimod for safety and efficacy in ART-treated HIV-1 infected controllers has completed with results posted.
-
FDA approval · 2021-04-02FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s generic emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) under an Original Application (ANDA), ma…
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: Strategy for Maintenance of HIV Suppression With Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children [Phase 2, Phase 3]
Clinical trial update on strategies to maintain HIV suppression in children using an integrase inhibitor plus darunavir/ritonavir; completed…
-
CLINICAL_TRIALS trial_result · 2021-03-26Clinical Trial Update: Effects of Metformin During Nicotine Withdrawal [Phase 2]
Phase 2 clinical trial investigating the effects of metformin during nicotine withdrawal; study completed with results posted.
-
FDA approval · 2021-03-24FDA Approved: VIRACEPT — Supplemental Application (AGOURON)
FDA approved a supplemental application for Viracept (nelfinavir mesylate) from Agouron. The approval acknowledges a change to the product v…